A Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients With Moderate to Severe Hidradenitis Suppurativa
Clinical trial NCT06603077 · COMPLETED
Trial details
- NCT number
- NCT06603077
- Sponsor
- Avalo Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-16
- Primary completion
- 2026-02-23
- Enrollment
- 253
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.